Overview

Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)

Status:
Unknown status
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
It is hoped that with the use of medication, occurs improvement of the CVI parameters, such as edema, pain, night cramps, functional discomfort, heavy feeling and that the drug test is non-inferior than the comparator.
Phase:
Phase 3
Details
Lead Sponsor:
Azidus Brasil